Table 2

Characteristics of the hospitalised COVID-19 cohort grouped by their outcomes

Still hospitalisedDeceasedDischargedTotalP value
n82574217063273
Age, median(Q1,Q3)67(57,77)75(65,84)60(46,71)65(53,77)<0.001
Sex, n (%)
FEMALE331 (40.1)297 (40.0)771 (45.2)1399 (42.7)0.013
MALE494 (59.9)445 (60.0)935 (54.8)1874 (57.3)
Race, n (%)
AFRICAN-AMERICAN198 (24.0)183 (24.7)435 (25.5)816 (24.9)0.025
ASIAN43 (5.2)32 (4.3)71 (4.2)146 (4.5)
HISPANIC252 (30.5)184 (24.8)519 (30.4)955 (29.2)
OTHER119 (14.4)108 (14.6)234 (13.7)461 (14.1)
UNKNOWN39 (4.7)29 (3.9)53 (3.1)121 (3.7)
WHITE174 (21.1)206 (27.8)394 (23.1)774 (23.6)
Smoking status, n (%)
NEVER432 (52.4)354 (47.7)954 (55.9)1740 (53.2)<0.001
NOT ASKED194 (23.5)166 (22.4)380 (22.3)740 (22.6)
QUIT165 (20.0)197 (26.5)315 (18.5)677 (20.7)
YES34 (4.1)25 (3.4)57 (3.3)116 (3.5)
BMI (kg/m2), median(Q1,Q3)27.6(24.1,32.6)27.6(23.9,32.5)28.3(24.8,32.7)28.1(24.4,32.7)0.067
Temperature (C), median(Q1,Q3)37.1(36.7,37.7)37.0(36.6,37.8)37.2(36.8,37.9)37.1(36.7,37.8)<0.001
Max. temperature (C), median(Q1,Q3)38.3(37.6,39.0)38.6(37.7,39.3)38.3(37.6,39.0)38.3(37.6,39.1)<0.001
O2 saturation (%), median(Q1,Q3)94.0(90.0,97.0)94.0(89.0,97.0)96.0(94.0,98.0)95.0(92.0,98.0)<0.001
Min. O2 saturation (%), median(Q1,Q3)88.0(81.0,91.0)78.0(64.0,86.0)91.0(89.0,94.0)90.0(82.0,92.0)<0.001
SBP (mmHg), median(Q1,Q3)128.0(115.0,145.0)130.0(111.0,149.0)129.0(116.8,143.0)129.0(115.0,145.0)0.872
DBP (mmHg), median(Q1,Q3)73.0(65.0,82.0)71.0(62.0,81.0)75.0(67.0,83.0)74.0(65.0,82.0)<0.001
High BP (SBP>140 or DBP>90), n (%)265 (32.1)261 (35.2)517 (30.3)1043 (31.9)0.058
Heart rate (BPM), median(Q1,Q3)96.0(84.0,112.0)95.0(82.0,110.0)96.0(84.0,108.0)96.0(84.0,110.0)0.310
Respiratory rate (BPM), median(Q1,Q3)20.0(18.0,24.0)20.0(18.0,24.0)19.0(18.0,20.0)20.0(18.0,22.0)<0.001
Respiratory rate>25, n (%)184 (22.3)160 (21.6)124 (7.3)468 (14.3)<0.001
Hypertension, n (%)295 (35.8)314 (42.3)473 (27.7)1082 (33.1)<0.001
Obesity, n (%)62 (7.5)56 (7.5)143 (8.4)261 (8.0)0.668
Diabetes, n (%)209 (25.3)213 (28.7)346 (20.3)768 (23.5)<0.001
HIV, n (%)15 (1.8)10 (1.3)27 (1.6)52 (1.6)0.758
Cancer, n (%)61 (7.4)62 (8.4)110 (6.4)233 (7.1)0.226
ALT (U/L), median(Q1,Q3)31.0(19.0,57.0)32.0(20.0,54.0)30.0(19.0,52.0)30.0(19.0,53.2)0.293
AST (U/L), median(Q1,Q3)44.0(31.0,72.0)57.0(36.8,91.0)40.0(28.0,61.0)44.0(30.0,72.0)<0.001
BUN (mg/dL), median(Q1,Q3)20.0(13.0,35.0)37.0(21.0,59.0)16.0(11.0,25.0)20.0(13.0,36.0)<0.001
CREATININE (mg/dL), median(Q1,Q3)1.1(0.8,1.6)1.4(1.0,2.3)0.9(0.7,1.3)1.0(0.8,1.6)<0.001
CREATININE>1.2, n (%)326 (39.5)439 (59.2)405 (23.7)1170 (35.7)<0.001
CRP (mg/L), median(Q1,Q3)140.9(75.3,221.2)169.8(95.5,253.2)93.5(50.6,168.9)124.2(60.3,204.3)<0.001
CRP>15, n (%)238 (28.8)212 (28.6)425 (24.9)875 (26.7)0.048
D-DIMER (UG/ML FEU), median(Q1,Q3)1.6(0.9,3.2)2.4(1.3,3.9)1.1(0.7,2.0)1.5(0.8,2.8)<0.001
D-DIMER>0.25, n (%)647 (78.4)402 (54.2)905 (53.0)1954 (59.7)<0.001
EGFR AA (ml/min/1.73 m2), median(Q1,Q3)40.5(22.7,52.2)36.6(23.0,51.2)35.8(14.3,48.5)37.2(20.8,51.1)0.051
EGFR non-AA (ml/min/1.73 m2), median(Q1,Q3)39.5(23.0,50.0)34.8(21.8,48.4)38.0(17.6,52.9)37.8(21.2,50.7)0.418
FERRITIN (NG/ML), median(Q1,Q3)891.0(422.2,1969.0)978.0(437.5,2331.8)613.5(274.2,1441.0)746.0(339.0,1795.0)<0.001
FERRITIN>300, n (%)560 (67.9)389 (52.4)756 (44.3)1705 (52.1)<0.001
FIBRINOGEN (mg/dL), median(Q1,Q3)644.0(533.8,752.0)627.0(525.5,752.5)594.5(486.0,701.8)623.0(506.0,736.0)<0.001
HGB (g/dL), median(Q1,Q3)13.4(11.9,14.5)12.9(11.2,14.4)13.4(12.3,14.6)13.3(11.9,14.5)0.003
LDH (U/L), median(Q1,Q3)464.0(354.0,629.0)516.0(384.0,758.0)386.0(297.0,495.5)432.0(324.0,576.0)<0.001
PROCALCITONIN (ng/mL), median(Q1,Q3)0.3(0.1,0.7)0.5(0.2,1.4)0.1(0.1,0.3)0.2(0.1,0.6)<0.001
PROCALCITONIN>0.5, n (%)229 (27.8)218 (29.4)174 (10.2)621 (19.0)<0.001
WCC (109/L), median(Q1,Q3)7.9(5.7,11.1)8.9(6.4,12.2)6.8(5.3,9.2)7.5(5.5,10.5)<0.001
WCC<4.5, n (%)83 (10.1)56 (7.5)214 (12.5)353 (10.8)0.001
WCC>11, n (%)201 (24.4)227 (30.6)219 (12.8)647 (19.8)<0.001
in_ICU, n (%)152 (18.4)228 (30.7)39 (2.3)419 (12.8)<0.001
Hospital, n (%)
MOUNT SINAI BI BROOKLYN119 (14.4)200 (27.0)229 (13.4)548 (16.8)<0.001
MOUNT SINAI QUEENS HOSPITAL136 (16.5)191 (25.8)197 (11.5)524 (16.0)
MOUNT SINAI ST. LUKE'S126 (15.3)128 (17.3)302 (17.7)556 (17.0)
MOUNT SINAI WEST78 (9.5)47 (6.4)238 (14.0)363 (11.1)
THE MOUNT SINAI HOSPITAL366 (44.4)174 (23.5)740 (43.4)1280 (39.1)
Infection status, n (%)
COVID-19723 (87.6)730 (98.4)1608 (94.3)3061 (93.5)<0.001
PUI - COVID102 (12.4)12 (1.6)98 (5.7)212 (6.5)
Days after infection, median(Q1,Q3)6.0(2.0,11.0)5.0(3.0,8.0)5.0(3.0,8.0)5.0(2.0,8.0)0.063
  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; BPM, breaths per minute; BUN, blood urea nitrogen; CRP, C reactive protein; DBP, diastolic blood pressure; D-Dimer, degradation dimer; EGFR, estiamted glomerular filtration rate; HGB, hemoglobin; ICU, intensive care unit; LDH, lactate dehydrogenase; PUI, patient under investigation; SBP, systolic blood pressure; WCC, white cell count.